Joshua T. Brumm, See Remarks at Dyne Therapeutics, Inc. (DYN), sold 3,322 shares at $10.87 ($36K) on 2022-12-12, disclosed to the SEC on 2022-12-13.
Scheduled sale ($36k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| DYN | SELL | 2024-03-12 | $22.2M | — | Filing → |
| DYN | SELL | 2024-03-11 | $470K | — | Filing → |
| DYN | SELL | 2024-03-01 | $5.1M | — | Filing → |